ABSTRACT
BACKGROUND: Psoriasis is an emerging paradoxical side effect in patients with inflammatory bowel disease (IBD) when treated with anti-TNF alpha. Patients with severe skin lesions unresponsive to topical therapy need to withdraw from treatment. AIM: To estimate the incidence of paradoxical psoriasis in a large cohort of IBD patients treated with anti-TNF alpha and to analyse its clinical correlates. METHODS: A retrospective cohort study on all IBD patients who started anti-TNF alpha at our IBD Centre from January 2008 to December 2013 was performed. Proportional hazards regression models were used to estimate the association between each predictor and time to the development of psoriasis. Time-dependent predictors were updated at each available time point. RESULTS: Four hundred and two patients were included. Participants contributed a total of 839 person-years of follow-up, during which 42 incident cases of psoriasis were recorded, with an incidence rate of five per 100 person-years. Cox-regression survival analysis revealed smoking as independent predictor of psoriasis (HR: 2.37, 95% CI: 1.36-4.48; P = 0.008). Conversely, concomitant immunosuppressive therapy was inversely related to psoriasis (HR: 0.33, 95% CI: 0.12-0.92; P = 0.03). CONCLUSIONS: Paradoxical psoriasis is a relevant side effect of anti-TNF alpha therapy, with an incidence rate of five per 100 person-years. Smoking is confirmed as the main risk factor for developing lesions. The combination therapy with anti-TNF alpha plus immunosuppressants is associated with a reduced risk of paradoxical psoriasis.
Subject(s)
Adalimumab/adverse effects , Immunosuppressive Agents/adverse effects , Inflammatory Bowel Diseases/drug therapy , Infliximab/adverse effects , Psoriasis/epidemiology , Psoriasis/etiology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adalimumab/therapeutic use , Adult , Aged , Cohort Studies , Female , Follow-Up Studies , Humans , Immunosuppressive Agents/therapeutic use , Incidence , Infliximab/therapeutic use , Male , Middle Aged , Psoriasis/diagnosis , Retrospective Studies , Risk Factors , Tumor Necrosis Factor-alpha/immunologyABSTRACT
Anti tumor necrosis factor antibodies are used to treat both psoriasis and inflammatory bowel disease. Several paradoxical cases of psoriatic skin lesions induced by tumor necrosis factor antagonist therapy have been described in IBD patients in the recent years. Ustekinumab, a fully human anti-interleukin-12/-23 monoclonal antibody, is the first drug of a new class of biologic therapy approved for the treatment of moderate to severe plaque psoriasis. Data on the efficacy of ustekinumab in patients with moderate-to-severe Crohn's disease, especially in patients previously treated with infliximab, have been recently published. We report about the effectiveness of ustekinumab in the treatment of both severe scalp psoriasis lesions with alopecia and active Crohn's disease.
Subject(s)
Alopecia/chemically induced , Antibodies, Monoclonal, Humanized/therapeutic use , Antibodies, Monoclonal/adverse effects , Crohn Disease/drug therapy , Psoriasis/chemically induced , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adult , Alopecia/drug therapy , Female , Humans , Infliximab , Psoriasis/drug therapy , UstekinumabABSTRACT
Sun exposure of the skin triggers several inflammatory pathways via a multitude of photochemical and photobiological effects. Furthermore, local and systemic immune suppression develops. The main clinical effects of UV exposure can be classified schematically into immediate, including sunburn, tanning, vitamin D production and exacerbation of inherited and acquired photosensitive skin disorders and long-term, including solar ageing and skin cancer. The protection against solar radiation is afforded by a healthy behavior of reasonable sun avoidance and the use of topical sunscreens as well as topical and oral antioxidants. However, users of sunscreen products should be able to choose correctly the more convenient product according to their needs. In Europe, the sun protection factor (SPF) and the UVA-protection factor (UVA-PF) are labeled to indicate the degree of protection against UVB and UVA, respectively. However, dermatologists must be aware that the present knowledge of UV effects on human skin needs to be clarified and several regulatory issues of photo-protection remain to be clarified and standardized. Finally, much work is needed to improve water resistance, spreadability, transparency and homogeneity of the sunscreen agents.
Subject(s)
Sunburn/etiology , Sunburn/prevention & control , Sunscreening Agents/therapeutic use , Ultraviolet Rays/adverse effects , Acute Disease , Chronic Disease , Humans , PhotobiologyABSTRACT
Sun exposure of the skin triggers several inflammatory pathways via a multitude of photochemical and photobiological effects. Furthermore, local and systemic immune suppression develops. The main clinical effects of UV exposure can be classified schematically into immediate, including sunburn, tanning, vitamin D production and exacerbation of inherited and acquired photosensitive skin disorders and long-term, including solar ageing and skin cancer. The protection against solar radiation is afforded by a healthy behavior of reasonable sun avoidance and the use of topical sunscreens as well as topical and oral antioxidants. However, users of sunscreen products should be able to choose correctly the most convenient product according to their needs. In Europe, the sun protection factor (SPF) and the UVA-protection factor (UVA-PF) are labeled to indicate the degree of protection against UVB and UVA, respectively. However, dermatologists must be aware that the present knowledge of UV effects on human skin needs to be clarified and several regulatory issues of photo-protection remain to be clarified and standardized. Finally, much work is needed to improve water resistance, spreadability, transparency and homogeneity of the sunscreen agents.
Subject(s)
Sunburn/prevention & control , Sunscreening Agents/administration & dosage , Administration, Topical , Humans , PhotobiologyABSTRACT
We describe a case of cutaneous tuberculosis in a 25-year-old Philippine man. Erythematous papulo-nodular lesions, measuring 0.5 to 1 cm, were present on lower limbs; a 2 cm nodule was located on the left flank. The examination of the skin biopsy showed the presence of a superficial and deep perivascular dermatitis with histiocytes, lymphocytes and plasma cells. Ziehl-Nielsen stain for mycobacterium were negative, while the cultural examination led to the isolation of M. tuberculosis. Direct smear and cultural examination of sputum for M. tuberculosis were negative; chest and skeletal roentgenograms, syphilis and HIV infection serology, haematological and hematochemical examinations and urinalysis were negative. Specific treatment with isoniazid, rifampin and ofloxacin led to a rapid remission of cutaneous lesions. This case was particularly difficult to classify, but the Authors think it would be considered a tuberculid.
Subject(s)
Tuberculosis, Cutaneous/classification , Adult , Biopsy , Diagnosis, Differential , Humans , Italy , Male , Philippines/ethnology , Skin/pathology , Tuberculosis, Cutaneous/diagnosis , Tuberculosis, Cutaneous/ethnologyABSTRACT
We have found that a remarkable improvement in the resolution of the details and in the richness of halftones can be obtained using 4" x 5" black-and-white professional films specifically prepared for scientific and documentary photography. Through modification of the developing time and developer dilution, a close control of the contrast and gray tones is also possible. Using this large-format film, a contact print can be made and top-quality pictures obtained even for a subject as difficult as skin pathology.
Subject(s)
Photomicrography/standards , Skin Diseases/pathology , Humans , Photomicrography/methods , Skin Neoplasms/pathologyABSTRACT
It has been demonstrated that topical application of all-trans retinoic acid and other retinoids can alter the hair-growth cycle in the C3H mouse model. The anagen phase is prolonged and the telogen phase is shortened. This effect is similar to the effect of minoxidil on the hair-cycle dynamics in this animal model. The levels of cellular retinoic acid binding protein measured by radioreceptor assay in whole skin of C3H mice were higher during anagen and lower during telogen. Topical application of certain retinoids caused elevated levels of cellular retinoic acid-binding protein (cRABP) in the whole skin homogenates during both phases of the cycle. Of the retinoids tested, those most effective in altering the levels of cRABP in the skin of the mice were also capable of significantly altering the hair-cycle dynamics. There appeared to be a relationship between the ability of retinoid to increase cRABP, increase 3H-thymidine incorporation, and alter the dynamics of the hair cycle. Only cRABP-II is detectable in human cultured dermal fibroblasts and dermal papilla cells. Dermal fibroblasts showed higher amounts of cRABP-II as compared to dermal papilla cells. The difference in cRABP-II expression might explain a distinct response to RA by these two cell populations. Whether the difference in expression of cRABP-II might be of physiologic importance remains to be determined. Treatment of human dermal papilla cells in culture with retinoic acid does not appear to affect proliferation, at least at the doses tested.
Subject(s)
Hair/cytology , Retinoids/pharmacology , Animals , Carrier Proteins/analysis , Cell Cycle/drug effects , Cells, Cultured/chemistry , Female , Fibroblasts/chemistry , Hair/drug effects , Hair/growth & development , Mice , Mice, Inbred C3H , Receptors, Retinoic Acid , Skin/chemistry , Skin/cytology , Skin/drug effectsABSTRACT
The principal functions of the skin include protection, excretion, secretion, absorption, thermoregulation, pigmentogenesis, accumulation, sensory perception and regulation of immunological processes. These functions are all affected by the structural changes in the skin with ageing and, after middle age, most functions are reduced, some by as much as 50-60%. The physiological changes associated with these reductions include impairment of the barrier function, decreased turnover of epidermal cells, reduced numbers of keratinocytes and fibroblasts, and a reduced vascular network particularly around hair bulbs and glands. These changes result in fibrosis and atrophy, and decreases in hair and nail growth, vitamin D synthesis and the density of Langerhans cells. Production of epidermal thymocyte-activating factor, which enhances the T-cell response, is reduced leading to a decrease in the immune response; there is also a decreased functioning of Meissner's and Pacinian corpuscles. An increased generation of free radicals is observed. Certain environmental factors, particularly exposure to sun, accelerate the ageing of skin and are important in cutaneous carcinogenesis.
Subject(s)
Skin Aging/physiology , Adult , Aged , Aged, 80 and over , Free Radicals , Humans , Middle Aged , Sebum/metabolism , Skin/blood supply , Skin/innervation , Skin Absorption/physiology , Skin Aging/immunology , Vitamin D/metabolismABSTRACT
Early Kaposi's sarcoma might be simulated by many different conditions, especially when the vascular component is prominent. the criteria suggested to differentiate early Kaposi's simulators are discussed. We found that these criteria are high in sensibility but low in specificity, therefore, we suggest using these criteria only when they are found in clusters.